Celsius Stock Plummets 3.27% Despite 117% Revenue Spike to 721M as 291st Most Traded

Market Snapshot

Celsius Holdings (CELH) experienced a 3.27% decline in its stock price on March 4, 2026, despite a 33.36% surge in trading volume to $0.42 billion, ranking 291st in daily market activity. The company’s recent earnings report revealed a 117.2% year-over-year revenue jump to $721.63 million in Q4 2025, driven by the acquisition of Alani Nu and expanded distribution. However, gross margin fell to 47.4% from 50.2% due to integration costs, and net income dropped to $63.8 million amid termination fees and higher interest expenses.

Key Drivers

The stock’s decline follows a mixed earnings report highlighting both robust revenue growth and margin pressures. Celsius’s Q4 2025 revenue of $721.63 million exceeded estimates by 12.9%, fueled by Alani Nu’s integration into PepsiCo’s distribution system, which generated over $1 billion in annual revenue. This acquisition expanded Celsius’s market reach and product portfolio, particularly among wellness-focused consumers. However, gross margin contraction to 47.4%—down from 50.2%—due to Alani Nu’s integration costs, combined with $327.5 million in distributor termination fees, weighed on profitability. Analysts noted that while adjusted EBITDA surged 113% to $134.1 million, the decline in net income to $63.8 million from $107.5 million the prior year signaled ongoing operational challenges.

The company’s strategic shift toward a multi-brand platform, including new product lines like CELSIUSCELH-3.27% Hydration and Alani Nu’s skincare-focused offerings, has bolstered revenue but introduced complexity. The transition to broader distribution channels, while beneficial for scale, has incurred one-time costs that temporarily depressed margins. Additionally, Celsius’s guidance for Q1 2026 (EPS $0.28, revenue $707 million) and Q2 2026 (EPS $0.50, revenue $886 million) reflects confidence in future growth but underscores near-term integration hurdles.

International revenue performance further complicated the outlook. While domestic operations drove the majority of growth, overseas segments underperformed expectations. Asia-Pacific revenue fell 19.89% short of forecasts to $2.83 million, and “Other International” revenue dropped 40.43% to $1.4 million. These declines, attributed to weaker-than-expected demand in non-core markets, contrasted with strong U.S. and Canadian results. The company’s reliance on domestic markets highlights risks in its global expansion strategy.

Analyst sentiment remains divided, contributing to the stock’s volatility. UBS Group raised its price target to $70, reiterating a “buy” rating, while Weiss Ratings maintained a “sell (D+)” stance. The mixed coverage reflects uncertainty over Celsius’s ability to sustain margins amid integration costs and competitive pressures. Despite the 3.27% drop on March 4, the stock’s 12-month average rating of “Moderate Buy” and consensus price target of $67.72 suggest underlying optimism about long-term potential, contingent on successful execution of its multi-brand strategy.

Conclusion

Celsius Holdings’ stock performance reflects a tug-of-war between strong revenue growth and margin pressures. While the Alani Nu acquisition and expanded distribution channels have driven top-line success, integration costs and international challenges have clouded profitability. The company’s guidance and analyst ratings indicate a cautiously optimistic outlook, but near-term volatility is likely as it navigates operational complexities. Investors will closely watch Q1 2026 results to assess progress in stabilizing margins and scaling its multi-brand platform.